Inventage Lab

Inventage Lab ROE

The Return on Equity (ROE) of Inventage Lab (389470.KQ) as of Oct 22, 2026 is -13.12 %. In the previous year, Return on Equity (ROE) was -52.19 % — a change of -74.86% (higher).

ROE

-13.12 %

YoY

-74.86%

Last updated:

In 2025, Inventage Lab's return on equity (ROE) was -13.12 %, a -74.86% increase from the -52.19 % ROE in the previous year.

The Inventage Lab ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2019
56.74 KRW
Jan 1, 2020
-77.09 KRW
Jan 1, 2021
-35.00 KRW
Jan 1, 2022
-34.81 KRW
Jan 1, 2023
-612.03 KRW
Jan 1, 2024
-52.19 KRW
Jan 1, 2025
-13.12 KRW
The Inventage Lab ROE history
YEARROEYoY
-13.12 %-74.86%
-52.19 %-91.47%
-612.03 %+1,658.03%
-34.81 %-0.53%
-35.00 %-54.60%
-77.09 %-235.85%
56.74 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inventage Lab Stock analysis

What does Inventage Lab do? Inventage Lab, Inc. generates revenue through the research, manufacture, and sale of human medicines targeting male pattern baldness, dementia, and prostate cancer, as well as veterinary medicines including combination drugs and chemical castration agents. The company leverages its proprietary platforms for long-acting injections and genetic material drug delivery to develop and scale production of these products. Its human medicine segment focuses on therapeutic areas with significant market demand, while veterinary medicines serve agricultural and companion animal markets. The firm's business model centers on proprietary technology platforms applied to both human and veterinary pharmaceutical development. These platforms enable the company to create and mass-produce innovative drug delivery systems, which are critical for the efficacy of their medicine portfolios. Revenue streams are derived from direct sales of these medicines to healthcare providers and veterinary institutions within their target markets. Inventage Lab, Inc. operates with a dual focus on human and veterinary pharmaceuticals, utilizing its specialized platforms to address unmet medical needs in both sectors. The company's product range includes treatments for specific conditions like male pattern baldness and prostate cancer, alongside veterinary applications such as chemical castration agents, which are sold to relevant industry stakeholders in their respective markets. Inventage Lab is one of the most popular companies on Eulerpool.

ROE Details

Decoding Inventage Lab's Return on Equity (ROE)

Inventage Lab's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Inventage Lab's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Inventage Lab's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Inventage Lab’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Inventage Lab stock

Return on Equity (ROE) of Inventage Lab is -13.12 % in 2025.

Return on Equity (ROE) of Inventage Lab changed from -52.19 % to -13.12 %, representing a -74.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Inventage Lab since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Inventage Lab with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Inventage Lab

All Key Metrics — Inventage Lab